• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Why is cancer so difficult to cure?
Why is cancer so difficult to cure?

... Transcription factor DNA damage recognition protein Arrest cell growth Trigger apoptosis Different treatment may be needed depending which function altered ...
Document
Document

... associated with:  increased susceptibility to viral, protozoan, and fungal infections. Intracellular pathogens such as Candida albicans, Mycobacteria are often implicated, reflecting the importance of T cells in eliminating intracellular pathogens. also affect the humoral system, because of the re ...
Physiology for Pharmacy Students Tortora 13th Ebaa M Alzayadneh
Physiology for Pharmacy Students Tortora 13th Ebaa M Alzayadneh

... • Eosinophils leave capillaries and enter tissue fluid – Release histaminase, phagocytize antigenantibody complexes and effective against certain parasitic worms University of Jordan ...
T cells
T cells

... interaction of their inhibitory and activation receptors  Activation: Fc receptor CD16  ADCC – antibody-dependent cellular cytotoxicity  Inhibition – killer inhibitory receptors (Ly49, CD94-NKG2) ...
Adaptive Immune Responses in Cattle Mini
Adaptive Immune Responses in Cattle Mini

... CD335 is a typical marker for NK cells (including bovine NK cells) where it functions as a natural cytotoxicity-triggering molecule. Healthy animals do not express CD335 on WC1+ γδ T cells. However, following infection with FMDV a transient expression of CD335 is induced (as is the presence of intra ...
Progress Report
Progress Report

... response via educating the effector T cells (Teff) is a trait that has potential utility to treat various autoimmune diseases such as type 1 diabetes mellitus (T1D), systemic lupus erythematosus (SLE), and experimental autoimmune thyroiditis (EAT) among several others. However, the function of the C ...
Chapter 16
Chapter 16

AJS_Paper3_Autoimmunity
AJS_Paper3_Autoimmunity

... In a healthy human, the immune system works to identify and eradicate pathogens1. The human immune system is divided into two complement parts: the nonspecific or innate immune system and the specific or adaptive immune system. Each functions in a unique way and comprehension of these processes is i ...
2014 stem cell symposium - Translational Research Institute
2014 stem cell symposium - Translational Research Institute

... Associate Professor Kiarash Khoshterani, The University of Queensland Centre for Clinical Research and the Translational Research Institute Cellular and molecular biology of skin stem cells and endothelial cells Professor Melissa Little, Institute of Molecular Bioscience, The University of Queenslan ...
Passive and active immunity
Passive and active immunity

MODELING CELL HETEROGENEITY
MODELING CELL HETEROGENEITY

... of immune cells. However, if the heterogeneity is too great, discrimination between “self” and “other” antigens may be compromised leading to autoimmune diseases. Advances in flow cytometry and single cell proteomics are beginning to elucidate the molecular mechanisms governing the proper regulation ...
ImmunoGuard - Be A Champion USA
ImmunoGuard - Be A Champion USA

... variety of potentially harmful substances such as microorganisms as well as toxins and other foreign antigens with which we come in contact in our environment. Threats such as foreign substances or abnormal cells can also occur within the body. A healthy immune system is vital for the protection and ...
dag van de biomedici - Biomedische Wetenschappen VUB
dag van de biomedici - Biomedische Wetenschappen VUB

... mutation in the factor VIII (FVIII) and factor IX (FIX) gene, respectively. The disease is characterized by spontaneous intra-articular and soft tissue bleedings, which can result in crippling arthritis. Classic treatment for hemophilia is administering clotting factor concentrates that have disadva ...
Mary Louise Markert, MD, Ph.D.
Mary Louise Markert, MD, Ph.D.

... supervision to avoid infections, tumors, kidney damage and heart disease and a high rate of rejection caused by non-compliance in taking the necessary immunosuppressive drugs. To address this unmet need, Louise proposes that tolerance can be induced to unmatched donor liver by also transplanting don ...
(34.6 Æ 0.2 P 0.05), CD8 (22.6 Æ 0.4 P 0.05), CD4/CD8 (1.62 Æ
(34.6 Æ 0.2 P 0.05), CD8 (22.6 Æ 0.4 P 0.05), CD4/CD8 (1.62 Æ

Read More - Division of Rheumatology
Read More - Division of Rheumatology

... which has been shown to be intimately associated with the mechanisms of self-nonself discrimination as central function of the immune system. In 2005 Dr. Betty Diamond was recruited to be Director of Rheumatology; after a brief tenure at Columbia she accepted a position at the Feinstein Medical Res ...
Lecture-1-Allergy-immunology-and
Lecture-1-Allergy-immunology-and

... antigens or haptens 2. Damage occurs due to activation of the complement cascade 3. IgG and IgM antibodies against food antigens are common in health and disease 4. Tissue damage could occur if anti-food antibodies crossreact with tissue antigens, leading to an autoimmune response 5. Very little evi ...
Prof.Dr.Nahed Mounir Sherif Prof. Dr. Mona Mahmoud Hussein
Prof.Dr.Nahed Mounir Sherif Prof. Dr. Mona Mahmoud Hussein

... Plasma levels of CXCL13 provide an accurate test for defining the disease activity in RA patients (Rioja et al., 2008). Moreover, it was found that B cells have been implicated in the pathogenesis of SS and CXCL13 is a homeostatic chemokine that regulates B cell movement (Rotondi et al., 2007). Ther ...
The Lymphatic System and Immunity
The Lymphatic System and Immunity

... • These antigens make up the major histocompatibility complex (MHC) and are also called human leukocyte antigens (HLA) • This complex of antigens consists of thousands of molecules that vary from one individual to another ...
The Biological Basis of the Immune System as a Model for Intelligent
The Biological Basis of the Immune System as a Model for Intelligent

... adaptive response is highly specific for a particular pathogen. This occurs because the innate system agent will not alter itself on repeated exposure to a given pathogen; however, the adaptive system agent improves its response to the pathogen with each encounter of the same pathogen. Also, this ad ...
D.5 Antiviral Medications
D.5 Antiviral Medications

... The first neuraminidase inhibitors were designed by a team in Australia, and led to the production of zanamivir (Relenza) which was approved for use in 2000. It was closely followed by the production of oseltamivir (Tamiflu). Both drugs have a chemical structure similar to sialic acid and so are abl ...
Science Quotes
Science Quotes

... kinds of viruses normally infect cells by copying part of their DNA into the genetic code of a host cell. Most early trials of genetic medicines therefore co-opted retroviruses, replacing their harmful parts with genes intended to help treat a disease, such as cystic fibrosis or brain cancer. [Unfor ...
Recognition by human gut γδ cells of stress inducible major
Recognition by human gut γδ cells of stress inducible major

... microbial antigens, or self antigens that are general harbingers of epithelial cell “stress”, caused by infections or cell transformation. The products of non-polymorphic major histocompatibility complex (MHC) genes, of hitherto unknown function, were proposed to be such harbingers.2 ...
doc - Ragon Institute
doc - Ragon Institute

... mouse models that recapitulate human immunity and characterize human immune responses to HIV. Major efforts will include the use of human stem cells to reconstitute a human immune system in immunodeficient mice, testing the potential of HIV vaccines, and developing novel approaches to eradicate HIV ...
chapt19_lecture
chapt19_lecture

... histamine and increase inflammatory response – Lymphocytes: Immunity – Monocytes: Become macrophages ...
< 1 ... 320 321 322 323 324 325 326 327 328 ... 523 >

Cancer immunotherapy



Cancer immunotherapy (immuno-oncology) is the use of the immune system to treat cancer. Immunotherapies fall into three main groups: cellular, antibody and cytokine. They exploit the fact that cancer cells often have subtly different molecules on their surface that can be detected by the immune system. These molecules, known as cancer antigens, are most commonly proteins, but also include molecules such as carbohydrates. Immunotherapy is used to provoke the immune system into attacking the tumor cells by using these antigens as targets.Antibody therapies are the most successful immunotherapy, treating a wide range of cancers. Antibodies are proteins produced by the immune system that bind to a target antigen on the cell surface. In normal physiology the immune system uses them to fight pathogens. Each antibody is specific to one or a few proteins. Those that bind to cancer antigens are used to treat cancer. Cell surface receptors are common targets for antibody therapies and include the CD20, CD274, and CD279. Once bound to a cancer antigen, antibodies can induce antibody-dependent cell-mediated cytotoxicity, activate the complement system, or prevent a receptor from interacting with its ligand, all of which can lead to cell death. Multiple antibodies are approved to treat cancer, including Alemtuzumab, Ipilimumab, Nivolumab, Ofatumumab, and Rituximab.Cellular therapies, also known as cancer vaccines, usually involve the removal of immune cells from the blood or from a tumor. Immune cells specific for the tumor are activated, cultured and returned to the patient where the immune cells attack the cancer. Cell types that can be used in this way are natural killer cells, lymphokine-activated killer cells, cytotoxic T cells and dendritic cells. The only cell-based therapy approved in the US is Dendreon's Provenge, for the treatment of prostate cancer.Interleukin-2 and interferon-α are examples of cytokines, proteins that regulate and coordinate the behaviour of the immune system. They have the ability to enhance anti-tumor activity and thus can be used as cancer treatments. Interferon-α is used in the treatment of hairy-cell leukaemia, AIDS-related Kaposi's sarcoma, follicular lymphoma, chronic myeloid leukaemia and malignant melanoma. Interleukin-2 is used in the treatment of malignant melanoma and renal cell carcinoma.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report